MX2008002456A - Uso de ambroxol para el tratamiento de infecciones por rinovirus. - Google Patents

Uso de ambroxol para el tratamiento de infecciones por rinovirus.

Info

Publication number
MX2008002456A
MX2008002456A MX2008002456A MX2008002456A MX2008002456A MX 2008002456 A MX2008002456 A MX 2008002456A MX 2008002456 A MX2008002456 A MX 2008002456A MX 2008002456 A MX2008002456 A MX 2008002456A MX 2008002456 A MX2008002456 A MX 2008002456A
Authority
MX
Mexico
Prior art keywords
ambroxol
treatment
rhinovirus
rhinovirus infections
medical composition
Prior art date
Application number
MX2008002456A
Other languages
English (en)
Spanish (es)
Inventor
Anke Esperester
Liane Paul
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of MX2008002456A publication Critical patent/MX2008002456A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2008002456A 2005-08-25 2006-08-03 Uso de ambroxol para el tratamiento de infecciones por rinovirus. MX2008002456A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05107792 2005-08-25
PCT/EP2006/064999 WO2007023072A2 (en) 2005-08-25 2006-08-03 Use of ambroxol for the treatment of rhinovirus infections

Publications (1)

Publication Number Publication Date
MX2008002456A true MX2008002456A (es) 2008-04-07

Family

ID=35519889

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008002456A MX2008002456A (es) 2005-08-25 2006-08-03 Uso de ambroxol para el tratamiento de infecciones por rinovirus.

Country Status (8)

Country Link
US (1) US20080319087A1 (https=)
EP (1) EP1928444A2 (https=)
JP (1) JP2009506002A (https=)
BR (1) BRPI0614887A2 (https=)
CA (1) CA2619863A1 (https=)
MX (1) MX2008002456A (https=)
RU (1) RU2409356C2 (https=)
WO (1) WO2007023072A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA027291B1 (ru) * 2011-03-14 2017-07-31 Бёрингер Ингельхайм Интернациональ Гмбх Способ лечения острого фарингита с помощью гидрохлорида амброксола
KR101915056B1 (ko) 2012-04-10 2018-11-07 한미약품 주식회사 암브록솔, 레보드로프로피진 및 완충제를 포함하는 경구용 액상 제제 및 이의 제조방법
CN104606170A (zh) * 2015-02-04 2015-05-13 上海华源安徽仁济制药有限公司 一种盐酸氨溴索胶囊及其制备方法
CN105078896A (zh) * 2015-09-22 2015-11-25 青岛华之草医药科技有限公司 一种治疗咳嗽的药物盐酸氨溴索组合物干混悬剂
RU2701737C1 (ru) * 2018-06-28 2019-10-01 федеральное государственное бюджетное учреждение "Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации Лекарственное средство для терапии хронических ран
IT201800006909A1 (it) * 2018-07-04 2020-01-04 Polvere secca di ambroxolo per uso inalatorio con target bronchiale
US11013687B1 (en) * 2020-06-08 2021-05-25 Amcyte Pharma, Inc. Preventive and therapeutic treatment for COVID 19 and any other disease caused by SARS CoV 2
WO2021255129A1 (en) * 2020-06-16 2021-12-23 Spedding Research Solutions, Sas Novel use of a modulator of glucosylceramide degradation for viral infections
WO2022036272A1 (en) * 2020-08-13 2022-02-17 Texas Southern University Compositions for and methods of inhibiting sars-cov2 infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3610997A1 (de) * 1986-04-02 1987-10-15 Krewel Werke Gmbh Ambroxol-nasenspray
MXPA04002066A (es) * 2001-09-04 2005-02-17 Techno Network Shinoku Co Ltd Farmacos contra influenza.
US20050075403A1 (en) * 2003-10-02 2005-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of inflammation in the pharynx

Also Published As

Publication number Publication date
WO2007023072A3 (en) 2007-05-03
WO2007023072A2 (en) 2007-03-01
BRPI0614887A2 (pt) 2011-04-19
CA2619863A1 (en) 2007-03-01
JP2009506002A (ja) 2009-02-12
RU2409356C2 (ru) 2011-01-20
RU2008110933A (ru) 2009-09-27
EP1928444A2 (en) 2008-06-11
US20080319087A1 (en) 2008-12-25

Similar Documents

Publication Publication Date Title
MY155255A (en) Spiro-oxindole compounds and their use as therapeutic agents
DK1970059T3 (da) Lægemiddel med calciumdobesilat til behandling og profylakse af senelidelser
WO2008147864A3 (en) Methods of using piperazine compounds in treating sodium channel-mediated diseases or conditions
SG150531A1 (en) Use of meloxicam for the treatment of respiratory diseases in pigs
MX2009004561A (es) Derivados de pirazolilo con actividad analgesica y utiles en el tratamiento o profilaxis del dolor.
TW200635582A (en) Medicaments for the treatment or prevention of fibrotic diseases
TNSN07111A1 (en) Preparation and use of biphenyl-4-yl- carbonylamino acid derivatives for the treatment of obesity.
EA200802412A1 (ru) Терапевтические комбинации для сопровождающихся болью медицинских состояний
CL2008001932A1 (es) Compuestos derivados de 6-cicloamino-3-(piridin-4-il)imidazo[1,2-b]piridazina, inhibidores de cq1epsilon y/o ck1delta; procedimiento de preparacion; composicion farmaceutica que los comprende; y uso en el tratamiento de desordenes del sueno, trastorno del ritmo circadiano, cancer y enfermedad de alzheimer.
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
UA92000C2 (en) 1-benzylindole-2-carboxamide derivatives
NZ591525A (en) Methods of treatment of complicated skin and skin structure infections using single doses of oritavancin
ZA202006072B (en) Ret inhibitor for use in treating cancer having a ret alteration
TW200616608A (en) Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
MX2009007247A (es) Metodo para el tratamiento de afecciones asociadas con actividad aumentada de 5-lipoxigenasa y/o leucotrienos.
EA201300421A1 (ru) Комбинированная терапия для лечения инфекции hcv
WO2006047716A3 (en) Use of diindolylmethane-related indoles and growth factor receptor inhibitors for the treatment of human cytomegalovirus associated disease
ATE543492T1 (de) Behandlung von lungenkrebs
MX2009003532A (es) Tratamiento de hiperbilirrubinemia infantil utilizando bajas dosis de estansoporfina.
UA85471C2 (ru) Применение оксикодона для лечения висцеральной боли
MX2008002456A (es) Uso de ambroxol para el tratamiento de infecciones por rinovirus.
DK1670489T3 (da) Brug af xenon med hypotermi til behandling af neonatal asfyksi
TW200635595A (en) Medicaments for the treatment of prevention of fibrotic diseases
PL1732551T3 (pl) Perheksylina do leczenia przewlekłej niewydolności serca
BR112014005653A2 (pt) uso de 4-amino-5-fluoro-3[6-(4-metilpiperazin-1-il)-1h-benzimidazol-2-1l]1h-quinolin-ona no tratamento de câncer de em pacientes com insuficiência hepática moderada

Legal Events

Date Code Title Description
FA Abandonment or withdrawal